Literature DB >> 27056049

Predictors of inpatient mortality in patients with systemic sclerosis: a case control study.

Shiv T Sehra1, Andrew Kelly2, Joshua F Baker3,4, Chris T Derk3.   

Abstract

There are few studies on predictors of inpatient mortality in patients with systemic sclerosis (SSc). Knowledge of these predictors is important for the early identification of patients at high risk of inpatient death and for the recognition of modifiable factors. The aim of this study was to define factors associated with greater inpatient mortality in SSc. All admissions coded for SSc (ICD-9-710.1) at the Hospital of University of Pennsylvania, between 2001 and 2011, were reviewed. The diagnosis of SSc was confirmed, and deaths were identified by chart review. For each death, an age, sex, and race matched control with SSc (who did not die during their hospitalization) was identified. We hypothesized group differences in SSc characteristics, non-SSc co-morbidities, and admission labs. Group differences were analyzed using Student's t test as well as Chi(2) tests for dichotomous variables. Exposures associated with death in univariate analyses were used to form a final parsimonious multivariable logistic regression model. After analysis of 658 SSc admissions, 29 cases and 29 matched controls were studied. A significant difference in non-SSc lung disease (p = 0.03), aspiration events (p < 0.01), blood urea nitrogen (BUN) (p < 0.01), and hemoglobin (p = 0.03) was noted between subjects that died compared to matched controls. Odds of death were higher in patients with a higher BUN (OR = 1.06, CI = 1.02-1.11), non-SSc lung disease (OR = 3.87, CI = 1.26-11.88), and aspiration events (OR = 30, CI = 3.58-250.80) and lower in patients with a higher hemoglobin (OR = 0.73, CI = 0.54-0.97). A high BUN, a history of aspiration events, and low Hgb were found to be independently associated with risk of death. A history of lung disease, anemia, renal dysfunction, and aspiration events is associated with higher in-hospital mortality in patients with SSc. The odds of dying in the hospital were 30 times higher among patients with an aspiration event. Stringent measures should be considered to prevent aspiration in at-risk patients.

Entities:  

Keywords:  Aspiration pneumonia; Gastroesophageal reflux; Hospital; Inpatient; Mortality; Scleroderma; Systemic sclerosis

Mesh:

Year:  2016        PMID: 27056049     DOI: 10.1007/s10067-016-3245-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease.

Authors:  A J Barnett; M H Miller; G O Littlejohn
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

Review 2.  The ABC's of stroke complications.

Authors:  W David Freeman; Steven B Dawson; Kelly D Flemming
Journal:  Semin Neurol       Date:  2011-01-04       Impact factor: 3.420

3.  Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis.

Authors:  Xuli Jerry Zhang; Ashley Bonner; Marie Hudson; Murray Baron; Janet Pope
Journal:  J Rheumatol       Date:  2013-04-01       Impact factor: 4.666

4.  Esophageal involvement and pulmonary manifestations in systemic sclerosis.

Authors:  I Marie; S Dominique; H Levesque; P Ducrotté; P Denis; M F Hellot; H Courtois
Journal:  Arthritis Rheum       Date:  2001-08

5.  An historical account of the study of progressive systemic sclerosis (diffuse scleroderma).

Authors:  G P RODNAN; T G BENEDEK
Journal:  Ann Intern Med       Date:  1962-08       Impact factor: 25.391

6.  Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.

Authors:  Anthony J Tyndall; Bettina Bannert; Madelon Vonk; Paolo Airò; Franco Cozzi; Patricia E Carreira; Dominique Farge Bancel; Yannick Allanore; Ulf Müller-Ladner; Oliver Distler; Florenzo Iannone; Raffaele Pellerito; Margarita Pileckyte; Irene Miniati; Lidia Ananieva; Alexandra Balbir Gurman; Nemanja Damjanov; Adelheid Mueller; Gabriele Valentini; Gabriela Riemekasten; Mohammed Tikly; Laura Hummers; Maria J S Henriques; Paola Caramaschi; Agneta Scheja; Blaz Rozman; Evelien Ton; Gábor Kumánovics; Bernard Coleiro; Eva Feierl; Gabriella Szucs; Carlos Alberto Von Mühlen; Valeria Riccieri; Srdan Novak; Carlo Chizzolini; Anna Kotulska; Christopher Denton; Paulo C Coelho; Ina Kötter; Ismail Simsek; Paloma García de la Pena Lefebvre; Eric Hachulla; James R Seibold; Simona Rednic; Jirí Stork; Jadranka Morovic-Vergles; Ulrich A Walker
Journal:  Ann Rheum Dis       Date:  2010-06-15       Impact factor: 19.103

7.  Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample.

Authors:  L Chung; E Krishnan; E F Chakravarty
Journal:  Rheumatology (Oxford)       Date:  2007-11-06       Impact factor: 7.580

8.  Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis.

Authors:  Sittichai Netwijitpan; Chingching Foocharoen; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Ratanavadee Nanagara
Journal:  Clin Rheumatol       Date:  2012-12-08       Impact factor: 2.980

9.  Predictors of survival in systemic sclerosis (scleroderma).

Authors:  R D Altman; T A Medsger; D A Bloch; B A Michel
Journal:  Arthritis Rheum       Date:  1991-04

10.  Initial predictors of survival in patients with systemic sclerosis (scleroderma).

Authors:  J Kaburaki; C C Lee; M Kuwana; T Tojo; Y Ikeda; M Takano; Y Funatsu
Journal:  Keio J Med       Date:  1992-09
View more
  9 in total

1.  Reasons for hospitalization and in-hospital mortality in adults with systemic sclerosis: Analysis of the National Inpatient Sample.

Authors:  Joanna Potera; Augustine M Manadan
Journal:  J Scleroderma Relat Disord       Date:  2022-05-11

Review 2.  An Update on Systemic Sclerosis and its Perioperative Management.

Authors:  Zyad J Carr; John Klick; Brittany J McDowell; Jean G Charchaflieh; Kunal Karamchandani
Journal:  Curr Anesthesiol Rep       Date:  2020-08-29

3.  Acute hospitalization in a cohort of patients with systemic sclerosis: a 10-year retrospective cohort study.

Authors:  Joana Caetano; Frederico Batista; Marta C Amaral; Susana Oliveira; José D Alves
Journal:  Rheumatol Int       Date:  2021-09-03       Impact factor: 3.580

Review 4.  Determinants of mortality in systemic sclerosis: a focused review.

Authors:  Dilli Ram Poudel; Divya Jayakumar; Abhijeet Danve; Shiv Tej Sehra; Chris T Derk
Journal:  Rheumatol Int       Date:  2017-11-07       Impact factor: 2.631

5.  Hospitalisations related to systemic sclerosis and the impact of interstitial lung disease. Analysis of patients hospitalised at the University of Michigan, USA.

Authors:  Shobana Sankar; Mirette Habib; Sara Jaafar; Vivek Nagaraja; David Roofeh; Amber Young; Suiyuan Huang; Dinesh Khanna
Journal:  Clin Exp Rheumatol       Date:  2021-03-10       Impact factor: 4.862

Review 6.  Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections.

Authors:  Manuela Di Franco; Bruno Lucchino; Martina Spaziante; Cristina Iannuccelli; Guido Valesini; Giancarlo Iaiani
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

7.  Trends in Demographics, Hospitalization Outcomes, Comorbidities, and Mortality Risk among Systemic Sclerosis Patients.

Authors:  Oluyemisi Amoda; Virendrasinh Ravat; Sorabh Datta; Bipin Saroha; Rikinkumar S Patel
Journal:  Cureus       Date:  2018-05-14

8.  Anemia Is an Indicator for Worse Organ Damage Trajectories in Patients with Systemic Sclerosis: A Retrospective Study.

Authors:  Zhaohua Li; Dan Xu; Xintong Jiang; Ting Li; Yin Su; Rong Mu
Journal:  J Clin Med       Date:  2022-08-26       Impact factor: 4.964

9.  Assessment of hospitalization and mortality of scleroderma in-patients: a thirteen-year study.

Authors:  Saeedeh Shenavandeh; Razieh Naseri
Journal:  Reumatologia       Date:  2017-08-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.